Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiora Pharmaceuticals (KPRX) Return on Sales (2016 - 2025)

Kiora Pharmaceuticals (KPRX) has disclosed Return on Sales for 10 consecutive years, with 604.32% as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Return on Sales fell 60516.0% year-over-year to 604.32%, compared with a TTM value of 604.32% through Mar 2025, down 60462.0%, and an annual FY2024 reading of 0.22%, changed N/A over the prior year.
  • Return on Sales was 604.32% for Q1 2025 at Kiora Pharmaceuticals, down from 0.22% in the prior quarter.
  • Across five years, Return on Sales topped out at 5824.32% in Q3 2022 and bottomed at 831.2% in Q1 2021.
  • Average Return on Sales over 4 years is 1299.96%, with a median of 0.57% recorded in 2024.
  • The sharpest move saw Return on Sales surged 590409bps in 2022, then tumbled -60516bps in 2025.
  • Year by year, Return on Sales stood at 3483.0% in 2021, then soared by 67bps to 5824.32% in 2022, then plummeted by -100bps to 0.22% in 2024, then crashed by -272065bps to 604.32% in 2025.
  • Business Quant data shows Return on Sales for KPRX at 604.32% in Q1 2025, 0.22% in Q4 2024, and 0.31% in Q3 2024.